Decreased T-cell-mediated suppression of IgM-rheumatoid factor synthesis in rheumatoid arthritis

Nancy Olsen, Hugo E. Jasin

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Circulating B-cell precursors specific for rheumatoid factor (RF) are present in normal subjects but spontaneous in vitro synthesis of RF occurs only in rheumatoid arthritis (RA). The regulatory role of RF-specific suppressor T cells in this process was studied in pokeweed mitogen-stimulated in vitro cultures of peripheral blood mononuclear cells. Addition of graded numbers of suppressor T8(+) cells from RA patients to normal B cells resulted in consistently less suppression of IgM and RF synthesis than that achieved by normal suppressor T cells. A preculture systen was then used to probe for RF-specific suppressor precursor lymphocytes. RA T-cell populations failed to generate normal levels of RF-specific suppression during in vitro culture for 4 days. Incubation with human-aggregated IgG (HaIgG) resulted in an increase in RF-specific suppression to normal levels. The data indicate that induction and full expression of RF-specific suppressor T-cell function is blocked in vivo in RA but can be overcome in vitro by incubation with HaIgG.

Original languageEnglish (US)
Pages (from-to)38-49
Number of pages12
JournalClinical Immunology and Immunopathology
Volume42
Issue number1
DOIs
StatePublished - Jan 1 1987

Fingerprint

Rheumatoid Factor
Immunoglobulin M
Rheumatoid Arthritis
T-Lymphocytes
Immunoglobulin G
CD8-Positive T-Lymphocytes
Pokeweed Mitogens
B-Lymphoid Precursor Cells
Blood Cells
B-Lymphocytes
Lymphocytes
In Vitro Techniques
Population

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Pathology and Forensic Medicine
  • Immunology

Cite this

@article{dc77d1e4a2ed44c6a03da9ef7511bb76,
title = "Decreased T-cell-mediated suppression of IgM-rheumatoid factor synthesis in rheumatoid arthritis",
abstract = "Circulating B-cell precursors specific for rheumatoid factor (RF) are present in normal subjects but spontaneous in vitro synthesis of RF occurs only in rheumatoid arthritis (RA). The regulatory role of RF-specific suppressor T cells in this process was studied in pokeweed mitogen-stimulated in vitro cultures of peripheral blood mononuclear cells. Addition of graded numbers of suppressor T8(+) cells from RA patients to normal B cells resulted in consistently less suppression of IgM and RF synthesis than that achieved by normal suppressor T cells. A preculture systen was then used to probe for RF-specific suppressor precursor lymphocytes. RA T-cell populations failed to generate normal levels of RF-specific suppression during in vitro culture for 4 days. Incubation with human-aggregated IgG (HaIgG) resulted in an increase in RF-specific suppression to normal levels. The data indicate that induction and full expression of RF-specific suppressor T-cell function is blocked in vivo in RA but can be overcome in vitro by incubation with HaIgG.",
author = "Nancy Olsen and Jasin, {Hugo E.}",
year = "1987",
month = "1",
day = "1",
doi = "10.1016/0090-1229(87)90171-1",
language = "English (US)",
volume = "42",
pages = "38--49",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "1",

}

Decreased T-cell-mediated suppression of IgM-rheumatoid factor synthesis in rheumatoid arthritis. / Olsen, Nancy; Jasin, Hugo E.

In: Clinical Immunology and Immunopathology, Vol. 42, No. 1, 01.01.1987, p. 38-49.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Decreased T-cell-mediated suppression of IgM-rheumatoid factor synthesis in rheumatoid arthritis

AU - Olsen, Nancy

AU - Jasin, Hugo E.

PY - 1987/1/1

Y1 - 1987/1/1

N2 - Circulating B-cell precursors specific for rheumatoid factor (RF) are present in normal subjects but spontaneous in vitro synthesis of RF occurs only in rheumatoid arthritis (RA). The regulatory role of RF-specific suppressor T cells in this process was studied in pokeweed mitogen-stimulated in vitro cultures of peripheral blood mononuclear cells. Addition of graded numbers of suppressor T8(+) cells from RA patients to normal B cells resulted in consistently less suppression of IgM and RF synthesis than that achieved by normal suppressor T cells. A preculture systen was then used to probe for RF-specific suppressor precursor lymphocytes. RA T-cell populations failed to generate normal levels of RF-specific suppression during in vitro culture for 4 days. Incubation with human-aggregated IgG (HaIgG) resulted in an increase in RF-specific suppression to normal levels. The data indicate that induction and full expression of RF-specific suppressor T-cell function is blocked in vivo in RA but can be overcome in vitro by incubation with HaIgG.

AB - Circulating B-cell precursors specific for rheumatoid factor (RF) are present in normal subjects but spontaneous in vitro synthesis of RF occurs only in rheumatoid arthritis (RA). The regulatory role of RF-specific suppressor T cells in this process was studied in pokeweed mitogen-stimulated in vitro cultures of peripheral blood mononuclear cells. Addition of graded numbers of suppressor T8(+) cells from RA patients to normal B cells resulted in consistently less suppression of IgM and RF synthesis than that achieved by normal suppressor T cells. A preculture systen was then used to probe for RF-specific suppressor precursor lymphocytes. RA T-cell populations failed to generate normal levels of RF-specific suppression during in vitro culture for 4 days. Incubation with human-aggregated IgG (HaIgG) resulted in an increase in RF-specific suppression to normal levels. The data indicate that induction and full expression of RF-specific suppressor T-cell function is blocked in vivo in RA but can be overcome in vitro by incubation with HaIgG.

UR - http://www.scopus.com/inward/record.url?scp=0023067131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023067131&partnerID=8YFLogxK

U2 - 10.1016/0090-1229(87)90171-1

DO - 10.1016/0090-1229(87)90171-1

M3 - Article

VL - 42

SP - 38

EP - 49

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 1

ER -